| Treatment of allergic rhinitis during pregnancy. | |
| | |
MedLine Citation:
|
PMID: 12921487 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Allergic rhinitis is a frequent problem during pregnancy. In addition, physiological changes associated with pregnancy can affect the upper airways. Evidence-based guidelines on the management of allergic rhinitis have recently been published, the most recent being the Allergic Rhinitis and its Impact on Asthma (ARIA)--World Health Organization consensus. Many pregnant women experience allergic rhinitis and particular attention is required when prescribing drugs to these patients. Medication can be prescribed during pregnancy when the apparent benefit of the drug is greater than the apparent risk. Usually, there is at least one drug from each major class that can be safely utilised to control symptoms. All glucocorticosteroids are teratogenic in animals but, when the indication is clear (for diseases possibly associated, such as severe asthma exacerbation), the benefit of the drug is far greater than the risk. Inhaled glucocorticosteroids (e.g. beclomethasone or budesonide) have not been incriminated as teratogens in humans and are used by pregnant women who have asthma. A few histamine H(1)-receptor antagonists (H(1)-antihistamines) can safely be used as well. Most oral decongestants (except pseudoephedrine) are teratogenic in animals. There are no such data available for intra-nasal decongestants. Finally, pregnancy is not considered as a contraindication for the continuation of allergen specific immunotherapy. |
| | |
Authors:
|
Pascal Demoly; Vincent Piette; Jean-Pierre Daures |
Related Documents
:
|
12151857 - The myotoxicity of statins. 9298717 - Asthma in pregnancy. 9058407 - Migraine and pregnancy. 22346077 - Blastocyst cryopreservation using solid surface vitrification: a preliminary study. 6084247 - Immunohistochemical demonstration of pregnancy-associated plasma protein a (papp-a) in ... 15656217 - Successful management of cervical pregnancy by selective uterine artery embolization: a... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Drugs Volume: 63 ISSN: 0012-6667 ISO Abbreviation: Drugs Publication Date: 2003 |
Date Detail:
|
Created Date: 2003-08-18 Completed Date: 2004-02-10 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 7600076 Medline TA: Drugs Country: New Zealand |
Other Details:
|
Languages: eng Pagination: 1813-20 Citation Subset: IM |
Affiliation:
|
Department of Respiratory Medicine, INSERM U454, Hospital Arnaud de Villeneuve, University Hospital of Montpellier, 34295 Cedex 5 Montpellier, France. demoly@montp.inserm.fr |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Administration, Inhalation Animals Cholinergic Antagonists / administration & dosage, therapeutic use Chromones / therapeutic use Female Glucocorticoids / administration & dosage, adverse effects, therapeutic use Histamine H1 Antagonists / therapeutic use Humans Nasal Decongestants / adverse effects Practice Guidelines as Topic Pregnancy Pregnancy Complications / drug therapy* Rhinitis, Allergic, Perennial / drug therapy*, etiology Teratogens |
| Chemical | |
Reg. No./Substance:
|
0/Cholinergic Antagonists; 0/Chromones; 0/Glucocorticoids; 0/Histamine H1 Antagonists; 0/Nasal Decongestants; 0/Teratogens |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Pharmacological prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.
Next Document: Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes.